CervoMed
CRVO

CervoMed (CRVO) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$25.00Aug 12, 2026
Canaccord GenuityMaintainedBuy$18.00 from $27.00Aug 10, 2026
HC Wainwright & Co.MaintainedBuy$25.00Jul 15, 2026
HC Wainwright & Co.MaintainedBuy$25.00Jul 13, 2026
HC Wainwright & Co.MaintainedBuy$25.00Jul 9, 2026
HC Wainwright & Co.MaintainedBuy$25.00Apr 23, 2026
D. Boral CapitalMaintainedBuy$31.00Apr 22, 2026
D. Boral CapitalMaintainedBuy$31.00Apr 8, 2026
D. Boral CapitalMaintainedBuy$31.00Mar 19, 2026
Chardan CapitalMaintainedBuy$21.00 from $15.00Mar 18, 2026
Roth CapitalMaintainedBuy$11.00 from $19.00Mar 18, 2026
D. Boral CapitalMaintainedBuy$31.00Mar 16, 2026
Chardan CapitalMaintainedBuy$15.00Mar 5, 2026
D. Boral CapitalMaintainedBuy$31.00Mar 4, 2026
D. Boral CapitalMaintainedBuy$31.00Feb 18, 2026
HC Wainwright & Co.MaintainedBuy$25.00Dec 18, 2025
Cantor FitzgeraldInitiated CoverageOverweightDec 18, 2025
D. Boral CapitalMaintainedBuy$31.00Dec 5, 2025
D. Boral CapitalMaintainedBuy$31.00Dec 2, 2025
D. Boral CapitalMaintainedBuy$31.00Nov 11, 2025

Frequently asked questions

  • What is the latest analyst rating on CRVO?

    On Aug 12, 2026, HC Wainwright & Co. maintained CervoMed at Buy with a price target of $25.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.